Search Results - Conte, PierFranco

Refine Results
  1. 1
    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

    Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities by Dieci, Maria Vittoria, Orvieto, Enrico, Dominici, Massimo, Conte, PierFranco, Guarneri, Valentina

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment

    Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment by Frega, Stefano, Ferro, Alessandra, Bonanno, Laura, Guarneri, Valentina, Conte, PierFranco, Pasello, Giulia

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report

    Complete pathological response in a patient with multiple liver metastases from colon cancer treated with Folfox-6 chemotherapy plus bevacizumab: a case report by Malavasi, Norma, Ponti, Giovanni, Depenni, Roberta, Bertolini, Federica, Zironi, Sandra, Luppi, Gabriele, Conte, Pier Franco

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Potentiation by Tumor Necrosis Factor of Mitoxantrone Cytotoxicity to Human Ovarian Cancer Cell Lines

    Potentiation by Tumor Necrosis Factor of Mitoxantrone Cytotoxicity to Human Ovarian Cancer Cell Lines by Russo, Patrizia, Parodi, Silvio, Billi, Giovanna, Oliva, Cristina, Venturing, Marco, Noviello, Elvira, Conte, PierFranco

    Published 1992
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

    LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer by Bonanno, Laura, Zulato, Elisabetta, Pavan, Alberto, Attili, Ilaria, Pasello, Giulia, Conte, PierFranco, Indraccolo, Stefano

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Novel Nuclear Medicine Imaging Applications in Immuno-Oncology

    Novel Nuclear Medicine Imaging Applications in Immuno-Oncology by Frega, Stefano, Dal Maso, Alessandro, Pasello, Giulia, Cuppari, Lea, Bonanno, Laura, Conte, PierFranco, Evangelista, Laura

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report

    Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report by Ferro, Alessandra, Filoni, Angela, Pavan, Alberto, Pasello, Giulia, Guarneri, Valentina, Conte, PierFranco, Alaibac, Mauro, Bonanno, Laura

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Clinical Impact of Plasma and Tissue Next‐Generation Sequencing in Advanced Non‐Small Cell Lung Cancer: A Real‐World Experience

    Clinical Impact of Plasma and Tissue Next‐Generation Sequencing in Advanced Non‐Small Cell Lung Cancer: A Real‐World Experience by Bonanno, Laura, Pavan, Alberto, Ferro, Alessandra, Calvetti, Lorenzo, Frega, Stefano, Pasello, Giulia, Aprile, Giuseppe, Guarneri, Valentina, Conte, PierFranco

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

    Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists by Urso, Loredana, Cavallari, Ilaria, Silic-Benussi, Micol, Biasini, Lorena, Zago, Giulia, Calabrese, Fiorella, Conte, Pier Franco, Ciminale, Vincenzo, Pasello, Giulia

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?

    Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? by Bonanno, Laura, Dal Maso, Alessandro, Pavan, Alberto, Zulato, Elisabetta, Calvetti, Lorenzo, Pasello, Giulia, Guarneri, Valentina, Conte, PierFranco, Indraccolo, Stefano

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Potentiation of Topoisomerase I and II Inhibitors Cell Killing by Tumor Necrosis Factor: Relationship to DNA Strand Breakage Formation

    Potentiation of Topoisomerase I and II Inhibitors Cell Killing by Tumor Necrosis Factor: Relationship to DNA Strand Breakage Formation by Orengo, Giorgia, Noviello, Elvira, Cimoli, Guido, Pagnan, Gabriella, Parodi, Silvio, Venturini, Marco, Conte, Pier Franco, Schenone, Federico, Conzi, Gianfranco, Russo, Patrizia

    Published 1992
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

    Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients by Danesi, Romano, Innocenti, Federico, Fogli, Stefano, Gennari, Alessandra, Baldini, Editta, Di Paolo, Antonello, Salvadori, Barbara, Bocci, Guido, Conte, Pier Franco, Del Tacca, Mario

    Published 2002
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Bevacizumab Treatment for Advanced Breast Cancer

    Bevacizumab Treatment for Advanced Breast Cancer by Alvarez, Ricardo H., Guarneri, Valentina, Icli, Fikri, Johnston, Stephen, Khayat, David, Loibl, Sibylle, Martin, Miguel, Zielinski, Christoph, Conte, PierFranco, Hortobagyi, Gabriel N.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated with Immune‐Checkpoint Inhibitors

    Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated with Immune‐Checkpoint Inhibitors by Pavan, Alberto, Calvetti, Lorenzo, Dal Maso, Alessandro, Attili, Ilaria, Del Bianco, Paola, Pasello, Giulia, Guarneri, Valentina, Aprile, Giuseppe, Conte, PierFranco, Bonanno, Laura

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Trabectedin plus Pegylated Liposomal Doxorubicin: Retrospective Analysis in Heavily Pretreated Platinum-sensitive Ovarian Cancer

    Trabectedin plus Pegylated Liposomal Doxorubicin: Retrospective Analysis in Heavily Pretreated Platinum-sensitive Ovarian Cancer by Nicoletto, Maria Ornella, Baldoni, Alessandra, Casarin, Alessandra, Randon, Giovanni, Nardin, Margherita, Baretta, Zora, Lardelli, Pilar, Nieto, Antonio, Alfaro, Vicente, Rigamonti, Claudia, Conte, Pier Franco

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation

    Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation by Dominici, Massimo, Rasini, Valeria, Bussolari, Rita, Chen, Xiaohua, Hofmann, Ted J., Spano, Carlotta, Bernabei, Daniela, Veronesi, Elena, Bertoni, Filippo, Paolucci, Paolo, Conte, PierFranco, Horwitz, Edwin M.

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer

    A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer by Rugo, Hope S., Campone, Mario, Amadori, Dino, Aldrighetti, Daniela, Conte, PierFranco, Wardley, Andrew, Villanueva, Cristian, Melisko, Michelle, McHenry, M. Brent, Liu, David, Lee, Francis, Pivot, Xavier

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer

    Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer by Boscolo, Alice, Fortarezza, Francesco, Lunardi, Francesca, Comacchio, Giovanni, Urso, Loredana, Frega, Stefano, Menis, Jessica, Bonanno, Laura, Guarneri, Valentina, Rea, Federico, Conte, PierFranco, Calabrese, Fiorella, Pasello, Giulia

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

    Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment by Bonanno, Laura, Zago, Giulia, Marulli, Giuseppe, Del Bianco, Paola, Schiavon, Marco, Pasello, Giulia, Polo, Valentina, Canova, Fabio, Tonetto, Fabrizio, Loreggian, Lucio, Rea, Federico, Conte, PierFranco, Favaretto, Adolfo

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

    Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Th... by Baselga, José, Gelmon, Karen A., Verma, Shailendra, Wardley, Andrew, Conte, PierFranco, Miles, David, Bianchi, Giulia, Cortes, Javier, McNally, Virginia A., Ross, Graham A., Fumoleau, Pierre, Gianni, Luca

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: